SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-19-036136
Filing Date
2019-02-12
Accepted
2019-02-12 17:07:03
Documents
1
Group Members
JULIET TAMMENOMS BAKKERLONGITUDE VENTURE PARTNERS II, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d699290dsc13ga.htm SC 13G/A 69781
  Complete submission text file 0001193125-19-036136.txt   71557
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Subject) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88972 | Film No.: 19591880
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 650-854-5700
Longitude Capital Partners II, LLC (Filed by) CIK: 0001647491 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A